ISLAMABAD (Reuters) – Pakistan on Friday approved China’s CanSino Biologics Inc’s (CanSinoBIO) COVID-19 vaccine for emergency use, Health Minister Faisal Sultan said, the fourth candidate authorized in the South Asian nation of 220 million.
Pakistan, largely reliant on the GAVI/WHO COVAX initiative for poorer nations, has also allowed private companies to import coronavirus vaccines and has agreed to exempt such imports from price caps.
“Yes, correct,” Sultan texted Reuters after being asked if the Drug Regulation Authority had approved the vaccine.
To read the full article from the U.S. News and World Report, please click here